Summary:
Do you have leukemia or lymphoma?
If so, this clinical research study might be right for you. The Blood Cancer Study is an international study looking at a potential new treatment for patients with leukemia and lymphoma.
You may be able eligible to participate if you:
- are 18 years of age or older
- have been diagnosed with one of the following B-cell malignancies that has returned after treatment, or has not responded to treatment:
- chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL)
- aggressive lymphoma: diffuse large B-cell lymphoma (DLBCL), advanced grade follicular lymphoma (FL), FL transforming to DLBCL, transformed indolent lymphoma, or mantle cell lymphoma
- have previously received chemotherapy in combination with rituximab or an anti-CD20 agent to treat B-cell malignancy.